Attenuation of Lipopolysaccharide-Induced Inflammatory Responses through Inhibition of the NF-κB Pathway and the Increased NRF2 Level by a Flavonol-Enriched n-Butanol …
Pathologic hyperreactive inflammatory responses occur when there is excessive activation
of a proinflammatory NF-κB pathway and a reduced cytoprotective NRF2 cascade. The …
of a proinflammatory NF-κB pathway and a reduced cytoprotective NRF2 cascade. The …
Polyphenolic Natural Products Active In Silico Against SARS-CoV-2 Spike Receptor Binding Domains and Non-structural Proteins - A Review
The ongoing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic
has been proven to be more severe than the previous coronavirus outbreaks due to the …
has been proven to be more severe than the previous coronavirus outbreaks due to the …
[HTML][HTML] Deciphering antiviral efficacy of malaria box compounds against malaria exacerbating viral pathogens-Epstein Barr virus and SARS-CoV-2, an in silico study
In malaria endemic countries, coinfections and cotransmissions of different viral pathogens
are widely reported. Prior studies have shown that malaria can trigger the Epstein-Barr virus …
are widely reported. Prior studies have shown that malaria can trigger the Epstein-Barr virus …
Potential Cancer- and Alzheimer's Disease-Targeting Phosphodiesterase Inhibitors from Uvaria alba: Insights from In Vitro and Consensus Virtual Screening
Inhibition of the major cyclic adenosine monophosphate-metabolizing enzyme PDE4 has
shown potential for the discovery of drugs for cancer, inflammation, and neurodegenerative …
shown potential for the discovery of drugs for cancer, inflammation, and neurodegenerative …
[HTML][HTML] Identifying non-nucleoside inhibitors of RNA-dependent RNA-polymerase of SARS-CoV-2 through per-residue energy decomposition-based pharmacophore …
Abstract Background and Objective The current coronavirus disease-2019 (COVID-19)
pandemic has triggered a worldwide health and economic crisis. The severe acute …
pandemic has triggered a worldwide health and economic crisis. The severe acute …
Virtual combinatorial library screening of quinadoline B derivatives against SARS-CoV-2 RNA-dependent RNA polymerase
The unprecedented global health threat of SARS-CoV-2 has sparked a continued interest in
discovering novel anti-COVID-19 agents. To this end, we present here a computer-based …
discovering novel anti-COVID-19 agents. To this end, we present here a computer-based …
Tetrahydrobisbenzylisoquinoline alkaloids from Phaeanthus ophthalmicus inhibit target enzymes associated with type 2 diabetes and obesity
Diabetes and obesity are metabolic comorbidities declared by WHO as epidemics. Owing to
the purported pharmaceutical activities of plant-derived secondary metabolites, we …
the purported pharmaceutical activities of plant-derived secondary metabolites, we …
Mycobacterium tuberculosis Inhibitors Based on Arylated Quinoline Carboxylic Acid Backbones with Anti-Mtb Gyrase Activity
New antitubercular agents with either a novel mode of action or novel mode of inhibition are
urgently needed to overcome the threat of drug-resistant tuberculosis (TB). The present …
urgently needed to overcome the threat of drug-resistant tuberculosis (TB). The present …
New myxobacteria of the Myxococcaceae clade produce angiolams with antiparasitic activities
S Walesch, R Garcia, AB Mahmoud, F Panter… - Microbiology …, 2024 - Am Soc Microbiol
In the past century, microbial natural products have proven themselves to be substantial and
fruitful sources of anti-infectives. In addition to the well-studied Actinobacteria, understudied …
fruitful sources of anti-infectives. In addition to the well-studied Actinobacteria, understudied …
Computationally repurposed natural products targeting SARS-CoV-2 attachment and entry mechanisms
The search for effective and safe therapeutics and vaccines for COVID-19 is one of, if not the
top most, the top priorities in today's medicinal and pharmaceutical research. In COVID-19 …
top most, the top priorities in today's medicinal and pharmaceutical research. In COVID-19 …